Mount Yale Investment Advisors, LLC Supernus Pharmaceuticals, Inc. Transaction History

Mount Yale Investment Advisors, LLC

  • $1.2 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$30.84 - $49.51 $121,632 - $195,267
-3,944 Closed
0 $0
Q3 2018

Nov 13, 2018
SELL
$42.7 - $56.55 $79,934 - $105,861
-1,872 Reduced 32.19%
3,944 $178,000
Q2 2018

Aug 22, 2018
BUY
$44.1 - $59.85 $27,342 - $37,107
620 Added 11.93%
5,816 $348,000
Q1 2018

Jun 25, 2018
BUY
$37.15 - $46.9 $193,031 - $243,692
5,196 New
5,196 $238,000

Others Institutions Holding SUPN

# of Institutions
286
Shares Held
60.7M
Call Options Held
27.7K
Put Options Held
11.3K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $2.14B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Mount Yale Investment Advisors, LLC Portfolio

Follow Mount Yale Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mount Yale Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mount Yale Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email